ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,981.26
      -0.60%
      US Tech 100
      16,714.60
      -1.31%
      Dow Jones
      37,987.16
      0.56%
      Brent Oil
      86.875
      0.53%
      Bitcoin
      64,427.99
      1.45%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mereo BioPharma Group PLC (MREO)

      7. Mereo BioPharma Group PLC (MREO) News

      MREO Mereo BioPharma Group PLC

      2.585
      -0.065 (-2.45%)
      Last Updated: 13:56:27
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Mereo BioPharma Group PLC MREO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.065 -2.45% 2.585 13:56:27
      Open Price Low Price High Price Close Price Prev Close
      2.62 2.53 2.668 2.65
      more quote information »

      Recent News

      Date Time Source Heading
      4/03/202407:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
      3/27/202416:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
      3/05/202407:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
      2/09/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/06/202416:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/26/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/26/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202416:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
      1/08/202407:08EDGAR2Form 8-K - Current report
      1/08/202407:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
      1/02/202416:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      12/18/202316:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
      12/18/202316:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/29/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/16/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/23/202316:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/23/202316:01GLOBEMereo BioPharma Reports on Recent Program Developments and..
      10/17/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/14/202316:30GLOBEUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data..
      10/09/202308:00GLOBEUltragenyx to Present Setrusumab (UX143) Update at ASBMR..
      9/21/202307:00GLOBEMereo BioPharma to Participate in Fireside Chat at the 2023..
      9/20/202316:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/07/202307:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/07/202307:30GLOBEMereo BioPharma Reports Interim Financial Results for the..
      7/26/202316:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      7/06/202308:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/06/202308:00GLOBEUltragenyx Announces First Patients Dosed in Phase 3 Program..
      6/30/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      5/31/202307:00GLOBEMereo BioPharma to Present at the Jefferies Healthcare..
      5/23/202313:43GLOBEPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s..
      5/08/202312:46GLOBEMereo BioPharma Regains Compliance with Nasdaq Minimum Bid..
      5/05/202316:06GLOBEMereo BioPharma Announces Listing Transfer to Nasdaq Capital..

      Your Recent History

      NASDAQ
      MREO
      Mereo BioPharma
      Delayed Upgrade Clock